J Pediatr Intensive Care 2012; 01(04): 207-210
DOI: 10.3233/PIC-12034
Georg Thieme Verlag KG Stuttgart – New York

Extracorporeal life support for nonimmune hydrops fetalis

Russell G. Witt
a   Division of Cardiothoracic Surgery, UC Davis Medical Center, Sacramento, CA, USA
,
Gary W. Raff
a   Division of Cardiothoracic Surgery, UC Davis Medical Center, Sacramento, CA, USA
,
Jeff Van Gundy
b   Department of Pediatric Cardiology, UC Davis Medical Center, Sacramento, CA, USA
,
Ming-Sing Si
a   Division of Cardiothoracic Surgery, UC Davis Medical Center, Sacramento, CA, USA
› Author Affiliations

Subject Editor:
Further Information

Publication History

20 March 2012

10 June 2012

Publication Date:
28 July 2015 (online)

Abstract

A Down syndrome female born at 35 wk estimated gestational age with non-immune hydrops fetalis associated with a complete atrioventricular septal defect and large patent ductus arteriosus with hypoxemia, severe anasarca and hypotension was treated successfully with extracorporeal life support for severe cardiopulmonary failure leading to eventual hospital discharge and elective repair of her cardiac defect. The case demonstrates that extracorporeal life support may be an effective therapy when initiated early in patients with non-immune hydrops fetalis associated with significant cardiac abnormalities.